MX217078B - Uso de compuestos de aminoadamantano como inmunorreguladores. - Google Patents

Uso de compuestos de aminoadamantano como inmunorreguladores.

Info

Publication number
MX217078B
MX217078B MX9801496A MX9801496A MX217078B MX 217078 B MX217078 B MX 217078B MX 9801496 A MX9801496 A MX 9801496A MX 9801496 A MX9801496 A MX 9801496A MX 217078 B MX217078 B MX 217078B
Authority
MX
Mexico
Prior art keywords
aminoadamantane
immunoregulators
compounds
aminoadamantane compounds
neutrophils
Prior art date
Application number
MX9801496A
Other languages
English (en)
Other versions
MX9801496A (es
Inventor
Erich F Elstner
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of MX9801496A publication Critical patent/MX9801496A/es
Publication of MX217078B publication Critical patent/MX217078B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9801496A 1995-08-25 1996-08-21 Uso de compuestos de aminoadamantano como inmunorreguladores. MX217078B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531342A DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
PCT/EP1996/003678 WO1997007791A1 (en) 1995-08-25 1996-08-21 Use of aminoadamantane compounds as immunoregulators

Publications (2)

Publication Number Publication Date
MX9801496A MX9801496A (es) 1998-05-31
MX217078B true MX217078B (es) 2003-10-22

Family

ID=7770407

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801496A MX217078B (es) 1995-08-25 1996-08-21 Uso de compuestos de aminoadamantano como inmunorreguladores.

Country Status (21)

Country Link
US (2) US6172116B1 (es)
EP (2) EP0845984B1 (es)
JP (1) JPH11512093A (es)
KR (1) KR100392986B1 (es)
CN (1) CN1282452C (es)
AT (1) ATE234083T1 (es)
AU (1) AU718219B2 (es)
CA (1) CA2230159C (es)
CZ (1) CZ299356B6 (es)
DE (3) DE19531342B4 (es)
DK (1) DK0845984T3 (es)
EE (1) EE04261B1 (es)
ES (1) ES2193259T3 (es)
GE (1) GEP19991779B (es)
IL (1) IL123394A (es)
MX (1) MX217078B (es)
NO (1) NO319153B1 (es)
RU (1) RU2219916C2 (es)
UA (1) UA57711C2 (es)
WO (1) WO1997007791A1 (es)
ZA (1) ZA967137B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01010835A (es) * 1999-04-28 2003-07-14 Univ Kingston Composiciones y metodos para tratar amiloidosis.
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006011823A1 (fr) * 2004-06-24 2006-02-02 Akciju Sabiedriba 'olainfarm' Agent immunostimulateur et interférogène
CA2592320C (en) 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
US8901316B2 (en) * 2010-08-09 2014-12-02 Shionogi & Co., Ltd. Process for preparing aminoadamantyl carbamate derivatives
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
AU2017302305A1 (en) 2016-07-27 2019-02-14 Corium, LLC. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
CN109789113A (zh) 2016-07-27 2019-05-21 考里安国际公司 美金刚透皮递送系统
AU2017301928B2 (en) 2016-07-27 2023-04-06 Corium, LLC. Donepezil transdermal delivery system
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450761A (en) * 1967-03-30 1969-06-17 Sun Oil Co 1-aminoethyldimethyladamantane
DE4014672A1 (de) * 1990-05-08 1991-11-14 Werner E G Prof Dr Mueller Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

Also Published As

Publication number Publication date
RU2219916C2 (ru) 2003-12-27
AU718219B2 (en) 2000-04-13
NO980793D0 (no) 1998-02-25
CZ299356B6 (cs) 2008-07-02
CN1282452C (zh) 2006-11-01
CN1198669A (zh) 1998-11-11
DE10399029I1 (de) 2004-01-08
KR19990044096A (ko) 1999-06-25
EP1293201A3 (en) 2003-05-21
WO1997007791A1 (en) 1997-03-06
DE19531342A1 (de) 1997-02-27
ES2193259T3 (es) 2003-11-01
US6255348B1 (en) 2001-07-03
US6172116B1 (en) 2001-01-09
EP1293201A2 (en) 2003-03-19
UA57711C2 (uk) 2003-07-15
KR100392986B1 (ko) 2003-11-17
ZA967137B (en) 1997-03-12
IL123394A0 (en) 1998-09-24
EE04261B1 (et) 2004-04-15
IL123394A (en) 2004-07-25
NO980793L (no) 1998-02-25
DE69626650D1 (de) 2003-04-17
EP0845984A1 (en) 1998-06-10
JPH11512093A (ja) 1999-10-19
EE9800057A (et) 1998-08-17
EP0845984B1 (en) 2003-03-12
CA2230159C (en) 2008-02-26
AU6926396A (en) 1997-03-19
MX9801496A (es) 1998-05-31
DK0845984T3 (da) 2003-06-23
DE69626650T2 (de) 2003-12-18
GEP19991779B (en) 1999-10-05
ATE234083T1 (de) 2003-03-15
CZ52498A3 (cs) 1999-04-14
DE19531342B4 (de) 2007-11-29
NO319153B1 (no) 2005-06-27
CA2230159A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
IL123394A0 (en) Use of aminoadamantane compounds as immunoregulators
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
CA2135768A1 (en) Indolocarbazole imides and the use thereof
CA2131316A1 (en) A thrombin blood fraction for use in a medical procedure
IL126366A0 (en) Photopheresis treatment of leukocytes
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
CA2079342A1 (en) Multi-functional pharmaceutical compounds and methods of use
HU910681D0 (en) Medical solution
AU693833B2 (en) Products containing G-CSF and TNF binding protein
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
WO2003013424A3 (en) Use of r-nsaid compounds for anti-hiv treatment
GR3032363T3 (en) Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them
MD970254A (en) Use of melatonine for treatment of patients having a medicamental dependence
DE3664631D1 (en) Polyprenyl compounds, processes for preparing them, and pharmaceutical composition containing them
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
Salmaso et al. Serratia spp. bacteremias in AIDS/ARC patients.
TH24203A (th) อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
UA28288A (uk) Спосіб лікування шизофренії
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
GB9218223D0 (en) The use of a compound for the manufacture of a medicament for the treatment of hiv infection
UA10093A (uk) Спосіб лікування захворювань товстої кишки

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: S.C. JOHNSON & SON, INC.

MM Annulment or lapse due to non-payment of fees